Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Deep learning models for cell cycle phase prediction from single-cell RNA sequencing data.

Briefings in bioinformatics·2026
Same author

In Vivo Electron Paramagnetic Resonance Molecular Profiling of Tumor Microenvironment upon Tumor Progression to Malignancy in an Animal Model of Breast Cancer.

Molecular imaging and biology·2023
Same author

Training doctoral students in critical thinking and experimental design using problem-based learning.

BMC medical education·2023
Same author

Chemotherapeutic Activity of Pitavastatin in Vincristine Resistant B-Cell Acute Lymphoblastic Leukemia.

Cancers·2023
Same author

Biocompatible Monophosphonated Trityl Spin Probe, HOPE71, for In Vivo Measurement of pO<sub>2</sub>, pH, and [P<sub>i</sub>] by Electron Paramagnetic Resonance Spectroscopy.

Analytical chemistry·2022
Same author

Multi-Omics Immune Interaction Networks in Lung Cancer Tumorigenesis, Proliferation, and Survival.

International journal of molecular sciences·2022

Related Experiment Video

Updated: May 12, 2026

Modeling Chemotherapy Resistant Leukemia In Vitro
08:41

Modeling Chemotherapy Resistant Leukemia In Vitro

Published on: February 9, 2016

Bone marrow osteoblast vulnerability to chemotherapy.

Marieta Gencheva1, Ian Hare, Susan Kurian

  • 1Alexander B. Osborn Hematopoietic Malignancy and Transplantation Program of the Mary Babb Randolph Cancer Center, Robert C. Byrd Health Sciences Center, West Virginia University School of Medicine, Morgantown, WV 26506-9300, USA.

European Journal of Haematology
|April 5, 2013
PubMed
Summary

Chemotherapy drugs like etoposide and melphalan disrupt osteoblast function, impairing the bone marrow microenvironment

More Related Videos

Development of a Human Preclinical Model of Osteoclastogenesis from Peripheral Blood Monocytes Co-cultured with Breast Cancer Cell Lines
06:00

Development of a Human Preclinical Model of Osteoclastogenesis from Peripheral Blood Monocytes Co-cultured with Breast Cancer Cell Lines

Published on: September 13, 2017

Murine Hind Limb Long Bone Dissection and Bone Marrow Isolation
07:17

Murine Hind Limb Long Bone Dissection and Bone Marrow Isolation

Published on: April 14, 2016

Related Experiment Videos

Last Updated: May 12, 2026

Modeling Chemotherapy Resistant Leukemia In Vitro
08:41

Modeling Chemotherapy Resistant Leukemia In Vitro

Published on: February 9, 2016

Development of a Human Preclinical Model of Osteoclastogenesis from Peripheral Blood Monocytes Co-cultured with Breast Cancer Cell Lines
06:00

Development of a Human Preclinical Model of Osteoclastogenesis from Peripheral Blood Monocytes Co-cultured with Breast Cancer Cell Lines

Published on: September 13, 2017

Murine Hind Limb Long Bone Dissection and Bone Marrow Isolation
07:17

Murine Hind Limb Long Bone Dissection and Bone Marrow Isolation

Published on: April 14, 2016

Area of Science:

  • Bone Biology
  • Hematopoiesis
  • Cancer Therapeutics

Background:

  • Osteoblasts are crucial for the bone marrow microenvironment, supporting hematopoietic cell development.
  • Disruption of the bone marrow niche, including osteoblasts, can negatively impact hematopoiesis.
  • Chemotherapy agents are widely used but their effects on osteoblasts are not fully understood.

Purpose of the Study:

  • To investigate the impact of etoposide (VP16) and melphalan on murine osteoblasts.
  • To determine how these chemotherapy drugs affect osteoblast maturation and function.
  • To elucidate the mechanisms by which chemotherapy might impair the bone marrow's support for hematopoiesis.

Main Methods:

  • Treatment of murine osteoblasts at different maturation stages with etoposide (VP16) and melphalan.
  • Analysis of osteoblast maturation markers.
  • Quantification of CXCL12 protein levels.
  • Measurement of extracellular matrix (ECM) component transcripts (OPN, OCN, Col1a1).

Main Results:

  • Etoposide (VP16) and melphalan delayed osteoblast maturation and altered CXCL12 protein levels.
  • Sublethal concentrations of these drugs reduced ECM component transcripts (osteopontin, osteocalcin, collagen 1A1).
  • Discrepancies between transcript and protein levels suggest complex regulatory responses to chemotherapy.

Conclusions:

  • The osteoblast compartment within the bone marrow niche is susceptible to chemotherapy-induced functional impairment.
  • Chemotherapy's disruption of osteoblast ECM synthesis may hinder hematopoietic recovery and alter marrow architecture.
  • Understanding these mechanisms is vital for improving patient recovery strategies post-transplantation.